OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease
E. M. Suleimen, Rani Alphonsa Jose, Raigul N. Suleimen, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1636-1636
Open Access | Times Cited: 25

Showing 25 citing articles:

Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1903-1917
Open Access | Times Cited: 81

Advances in the study of the function and mechanism of the action of flavonoids in plants under environmental stresses
Jieting Wu, Sidi Lv, Lei Zhao, et al.
Planta (2023) Vol. 257, Iss. 6
Closed Access | Times Cited: 56

New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies
Eslam B. Elkaeed, Mohammed S. Taghour, Hazem A. Mahdy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2191-2205
Open Access | Times Cited: 53

The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1H-Indole Derivative: In Silico and In Vitro Approaches
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Processes (2022) Vol. 10, Iss. 7, pp. 1391-1391
Open Access | Times Cited: 45

Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0272362-e0272362
Open Access | Times Cited: 40

Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies
Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11535-11550
Open Access | Times Cited: 30

Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs
Eslam B. Elkaeed, Hazem Elkady, Amany Belal, et al.
Processes (2022) Vol. 10, Iss. 3, pp. 530-530
Open Access | Times Cited: 36

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34

New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 5859-5859
Open Access | Times Cited: 31

Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies
Reda G. Yousef, Alaa Elwan, Ibraheem M. M. Gobaara, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2206-2222
Open Access | Times Cited: 30

Traditional Use, Phytochemical Profiles and Pharmacological Properties of Artemisia Genus from Central Asia
А.К. Нурлыбекова, Aidana Kudaibergen, Aizhan Kazymbetova, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5128-5128
Open Access | Times Cited: 28

Engineered production of bioactive polyphenolic O-glycosides
Jie Ren, Caleb Don Barton, Jixun Zhan
Biotechnology Advances (2023) Vol. 65, pp. 108146-108146
Closed Access | Times Cited: 16

In silico and in vitro evaluation of the anti-virulence potential of patuletin, a natural methoxy flavone, against Pseudomonas aeruginosa
Ahmed M. Metwaly, Moustafa M. Saleh, Aisha A. Alsfouk, et al.
PeerJ (2024) Vol. 12, pp. e16826-e16826
Open Access | Times Cited: 5

In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 16, pp. 7986-8001
Closed Access | Times Cited: 23

The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2
Ahmed M. Metwaly, Eslam B. Elkaeed, Bshra A. Alsfouk, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1886-1886
Open Access | Times Cited: 19

Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum
E. M. Suleimen, Rani Alphonsa Jose, G. К. Mamytbekova, et al.
Plants (2022) Vol. 11, Iss. 15, pp. 2072-2072
Open Access | Times Cited: 17

A New Theobromine-Based EGFRWT and EGFRT790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies
Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, et al.
Processes (2022) Vol. 10, Iss. 11, pp. 2290-2290
Open Access | Times Cited: 14

Computer aided drug discovery (CADD) of a thieno[2,3- d ]pyrimidine derivative as a new EGFR inhibitor targeting the ribose pocket
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2369-2391
Open Access | Times Cited: 7

New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluation
Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1153-1173
Closed Access | Times Cited: 7

A novel thieno[2,3‐d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor‐2: A story of computer‐aided drug discovery
Eman A. Sobh, Mohammed A. Dahab, Eslam B. Elkaeed, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1247-1265
Closed Access | Times Cited: 6

New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, in vitro , and in silico studies
Reda G. Yousef, Ibrahim H. Eissa, Hazem Elkady, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-18
Open Access | Times Cited: 2

Structural basis for the inhibition of the HCoV-NL63 main protease Mpro by X77
Jie Xu, Qinyao Zhu, Wenwen Li, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 724, pp. 150231-150231
Closed Access

HPLC-ESI-QTOF-MS/MS Analysis of Artemisia cina Leaves Aqueous Extract and Flavonoid Isolation Using High-speed Countercurrent Chromatography
Sonwabiso Tshunungwa, Bashaer Alsharif, Tolkyn Bekezhanova, et al.
Acta Poloniae Pharmaceutica - Drug Research (2024) Vol. 81, Iss. 2, pp. 319-330
Open Access

Isolation and in silico investigation of cannflavins from Cannabis sativa leaves as potential anti-SARS-CoV-2 agents targeting the Papain-Like Protease
Amira S. Wanas, Mohamed M. Radwan, Adel A. Marzouk, et al.
Natural Product Research (2023), pp. 1-14
Closed Access | Times Cited: 1

Page 1

Scroll to top